table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2030)
1.4.2 East Asia Market States and Outlook (2023-2030)
1.4.3 Europe Market States and Outlook (2023-2030)
1.4.4 South Asia Market States and Outlook (2023-2030)
1.4.5 Southeast Asia Market States and Outlook (2023-2030)
1.4.6 Middle East Market States and Outlook (2023-2030)
1.4.7 Africa Market States and Outlook (2023-2030)
1.4.8 Oceania Market States and Outlook (2023-2030)
1.4.9 South America Market States and Outlook (2023-2030)
1.5 Global Retinal Drugs and Biologics Market Size Analysis from 2023 to 2030
1.5.1 Global Retinal Drugs and Biologics Market Size Analysis from 2023 to 2030 by Consumption Volume
1.5.2 Global Retinal Drugs and Biologics Market Size Analysis from 2023 to 2030 by Value
1.5.3 Global Retinal Drugs and Biologics Price Trends Analysis from 2023 to 2030
1.6 COVID-19 Outbreak: Retinal Drugs and Biologics Industry Impact
Chapter 2 Global Retinal Drugs and Biologics Competition by Types, Applications, and Top Regions and Countries
2.1 Global Retinal Drugs and Biologics (Volume and Value) by Type
2.1.1 Global Retinal Drugs and Biologics Consumption and Market Share by Type (2017-2022)
2.1.2 Global Retinal Drugs and Biologics Revenue and Market Share by Type (2017-2022)
2.2 Global Retinal Drugs and Biologics (Volume and Value) by Application
2.2.1 Global Retinal Drugs and Biologics Consumption and Market Share by Application (2017-2022)
2.2.2 Global Retinal Drugs and Biologics Revenue and Market Share by Application (2017-2022)
2.3 Global Retinal Drugs and Biologics (Volume and Value) by Regions
2.3.1 Global Retinal Drugs and Biologics Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Retinal Drugs and Biologics Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Retinal Drugs and Biologics Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Retinal Drugs and Biologics Consumption by Regions (2017-2022)
4.2 North America Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
4.10 South America Retinal Drugs and Biologics Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Retinal Drugs and Biologics Market Analysis
5.1 North America Retinal Drugs and Biologics Consumption and Value Analysis
5.1.1 North America Retinal Drugs and Biologics Market Under COVID-19
5.2 North America Retinal Drugs and Biologics Consumption Volume by Types
5.3 North America Retinal Drugs and Biologics Consumption Structure by Application
5.4 North America Retinal Drugs and Biologics Consumption by Top Countries
5.4.1 United States Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
5.4.2 Canada Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
5.4.3 Mexico Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 6 East Asia Retinal Drugs and Biologics Market Analysis
6.1 East Asia Retinal Drugs and Biologics Consumption and Value Analysis
6.1.1 East Asia Retinal Drugs and Biologics Market Under COVID-19
6.2 East Asia Retinal Drugs and Biologics Consumption Volume by Types
6.3 East Asia Retinal Drugs and Biologics Consumption Structure by Application
6.4 East Asia Retinal Drugs and Biologics Consumption by Top Countries
6.4.1 China Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
6.4.2 Japan Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
6.4.3 South Korea Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 7 Europe Retinal Drugs and Biologics Market Analysis
7.1 Europe Retinal Drugs and Biologics Consumption and Value Analysis
7.1.1 Europe Retinal Drugs and Biologics Market Under COVID-19
7.2 Europe Retinal Drugs and Biologics Consumption Volume by Types
7.3 Europe Retinal Drugs and Biologics Consumption Structure by Application
7.4 Europe Retinal Drugs and Biologics Consumption by Top Countries
7.4.1 Germany Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.2 UK Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.3 France Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.4 Italy Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.5 Russia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.6 Spain Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.7 Netherlands Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.8 Switzerland Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
7.4.9 Poland Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 8 South Asia Retinal Drugs and Biologics Market Analysis
8.1 South Asia Retinal Drugs and Biologics Consumption and Value Analysis
8.1.1 South Asia Retinal Drugs and Biologics Market Under COVID-19
8.2 South Asia Retinal Drugs and Biologics Consumption Volume by Types
8.3 South Asia Retinal Drugs and Biologics Consumption Structure by Application
8.4 South Asia Retinal Drugs and Biologics Consumption by Top Countries
8.4.1 India Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
8.4.2 Pakistan Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Retinal Drugs and Biologics Market Analysis
9.1 Southeast Asia Retinal Drugs and Biologics Consumption and Value Analysis
9.1.1 Southeast Asia Retinal Drugs and Biologics Market Under COVID-19
9.2 Southeast Asia Retinal Drugs and Biologics Consumption Volume by Types
9.3 Southeast Asia Retinal Drugs and Biologics Consumption Structure by Application
9.4 Southeast Asia Retinal Drugs and Biologics Consumption by Top Countries
9.4.1 Indonesia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.2 Thailand Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.3 Singapore Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.4 Malaysia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.5 Philippines Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.6 Vietnam Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
9.4.7 Myanmar Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 10 Middle East Retinal Drugs and Biologics Market Analysis
10.1 Middle East Retinal Drugs and Biologics Consumption and Value Analysis
10.1.1 Middle East Retinal Drugs and Biologics Market Under COVID-19
10.2 Middle East Retinal Drugs and Biologics Consumption Volume by Types
10.3 Middle East Retinal Drugs and Biologics Consumption Structure by Application
10.4 Middle East Retinal Drugs and Biologics Consumption by Top Countries
10.4.1 Turkey Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.3 Iran Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.5 Israel Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.6 Iraq Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.7 Qatar Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.8 Kuwait Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
10.4.9 Oman Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 11 Africa Retinal Drugs and Biologics Market Analysis
11.1 Africa Retinal Drugs and Biologics Consumption and Value Analysis
11.1.1 Africa Retinal Drugs and Biologics Market Under COVID-19
11.2 Africa Retinal Drugs and Biologics Consumption Volume by Types
11.3 Africa Retinal Drugs and Biologics Consumption Structure by Application
11.4 Africa Retinal Drugs and Biologics Consumption by Top Countries
11.4.1 Nigeria Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
11.4.2 South Africa Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
11.4.3 Egypt Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
11.4.4 Algeria Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
11.4.5 Morocco Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 12 Oceania Retinal Drugs and Biologics Market Analysis
12.1 Oceania Retinal Drugs and Biologics Consumption and Value Analysis
12.2 Oceania Retinal Drugs and Biologics Consumption Volume by Types
12.3 Oceania Retinal Drugs and Biologics Consumption Structure by Application
12.4 Oceania Retinal Drugs and Biologics Consumption by Top Countries
12.4.1 Australia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
12.4.2 New Zealand Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 13 South America Retinal Drugs and Biologics Market Analysis
13.1 South America Retinal Drugs and Biologics Consumption and Value Analysis
13.1.1 South America Retinal Drugs and Biologics Market Under COVID-19
13.2 South America Retinal Drugs and Biologics Consumption Volume by Types
13.3 South America Retinal Drugs and Biologics Consumption Structure by Application
13.4 South America Retinal Drugs and Biologics Consumption Volume by Major Countries
13.4.1 Brazil Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.2 Argentina Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.3 Columbia Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.4 Chile Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.5 Venezuela Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.6 Peru Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
13.4.8 Ecuador Retinal Drugs and Biologics Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Retinal Drugs and Biologics Business
14.1 ALLERGAN
14.1.1 ALLERGAN Company Profile
14.1.2 ALLERGAN Retinal Drugs and Biologics Product Specification
14.1.3 ALLERGAN Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 AbbVie
14.2.1 AbbVie Company Profile
14.2.2 AbbVie Retinal Drugs and Biologics Product Specification
14.2.3 AbbVie Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Alimera Sciences
14.3.1 Alimera Sciences Company Profile
14.3.2 Alimera Sciences Retinal Drugs and Biologics Product Specification
14.3.3 Alimera Sciences Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Janssen Biotech
14.4.1 Janssen Biotech Company Profile
14.4.2 Janssen Biotech Retinal Drugs and Biologics Product Specification
14.4.3 Janssen Biotech Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Swedish Orphan Biovitrum
14.5.1 Swedish Orphan Biovitrum Company Profile
14.5.2 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Specification
14.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Roche
14.6.1 Roche Company Profile
14.6.2 Roche Retinal Drugs and Biologics Product Specification
14.6.3 Roche Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Bristol-Myers Squibb
14.7.1 Bristol-Myers Squibb Company Profile
14.7.2 Bristol-Myers Squibb Retinal Drugs and Biologics Product Specification
14.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Genzyme
14.8.1 Genzyme Company Profile
14.8.2 Genzyme Retinal Drugs and Biologics Product Specification
14.8.3 Genzyme Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Genentech
14.9.1 Genentech Company Profile
14.9.2 Genentech Retinal Drugs and Biologics Product Specification
14.9.3 Genentech Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 OCULAR THERAPEUTIX
14.10.1 OCULAR THERAPEUTIX Company Profile
14.10.2 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Specification
14.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Bausch & Lomb
14.11.1 Bausch & Lomb Company Profile
14.11.2 Bausch & Lomb Retinal Drugs and Biologics Product Specification
14.11.3 Bausch & Lomb Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 UCBCares
14.12.1 UCBCares Company Profile
14.12.2 UCBCares Retinal Drugs and Biologics Product Specification
14.12.3 UCBCares Retinal Drugs and Biologics Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Retinal Drugs and Biologics Market Forecast (2023-2030)
15.1 Global Retinal Drugs and Biologics Consumption Volume, Revenue and Price Forecast (2023-2030)
15.1.1 Global Retinal Drugs and Biologics Consumption Volume and Growth Rate Forecast (2023-2030)
15.1.2 Global Retinal Drugs and Biologics Value and Growth Rate Forecast (2023-2030)
15.2 Global Retinal Drugs and Biologics Consumption Volume, Value and Growth Rate Forecast by Region (2023-2030)
15.2.1 Global Retinal Drugs and Biologics Consumption Volume and Growth Rate Forecast by Regions (2023-2030)
15.2.2 Global Retinal Drugs and Biologics Value and Growth Rate Forecast by Regions (2023-2030)
15.2.3 North America Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.4 East Asia Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.5 Europe Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.6 South Asia Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.7 Southeast Asia Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.8 Middle East Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.9 Africa Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.10 Oceania Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.2.11 South America Retinal Drugs and Biologics Consumption Volume, Revenue and Growth Rate Forecast (2023-2030)
15.3 Global Retinal Drugs and Biologics Consumption Volume, Revenue and Price Forecast by Type (2023-2030)
15.3.1 Global Retinal Drugs and Biologics Consumption Forecast by Type (2023-2030)
15.3.2 Global Retinal Drugs and Biologics Revenue Forecast by Type (2023-2030)
15.3.3 Global Retinal Drugs and Biologics Price Forecast by Type (2023-2030)
15.4 Global Retinal Drugs and Biologics Consumption Volume Forecast by Application (2023-2030)
15.5 Retinal Drugs and Biologics Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
